Search for: "Boehringer-Ingelheim"
Results 21 - 40
of 441
Sorted by Relevance
|
Sort by Date
9 Aug 2009, 4:54 pm
Boehringer Ingelheim Pharma GmbH & Co. [read post]
29 Oct 2012, 11:40 am
Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
16 Sep 2010, 11:32 am
Boehringer Ingelheim (civil case) [uploaded: 09/16/2010] [read post]
9 Jul 2018, 10:00 pm
More from our authors: Mediation: Creating Value in International Intellectual Property Disputes by Théophile Margellos, Sophia Bonne, Gordon Humphreys, Sven Stürmann € The post Ireland: Re Boehringer Ingelheim Pharma GmbH & Co. [read post]
20 Aug 2010, 3:42 am
Hochberg of the District Court of the District of New Jersey lately ruled in the favor of Boehringer Ingelheim and found Boehringer’s US Patent Number 4,886,812 infringed and violated by Mylan’s generic version of Mirapex product. [read post]
6 Mar 2012, 6:27 pm
According to the complaint, the drug is defective and recommends that Boehringer Ingelheim should have issued a Pradaxa recall. [read post]
20 Mar 2012, 3:19 am
The study upon which it based those claims was funded by…you guessed it…Boehringer Ingelheim. [read post]
23 Apr 2007, 4:31 am
The IPKat notes that the ECJ will be delivering its judgment in the Boehringer Ingelheim parallel importation case this Thurusday. [read post]
16 Mar 2012, 2:12 pm
The British regulatory agency has cited Boehringer Ingelheim’s Pradaxa website for violating industry codes of conduct. [read post]
24 Jul 2008, 9:06 pm
The lawsuit alleges that Pfizer and Boehringer-Ingelheim may have been aware of these side effects before releasing the drug but failed to list them in their report to the FDA. [read post]
22 Oct 2012, 8:28 am
Boehringer Ingelheim Corp. [read post]
7 Nov 2017, 11:36 am
The most recent medical journal article we have seen concerning this drug safety issue singles out the SGLT2 inhibitors which contain the active empagliflozin, which are listed below: Jardiance (empagliflozin) — Boehringer Ingelheim Pharmaceuticals — FDA Approval: 2014 Glyxambi (empagliflozin and linagliptin) — Boehringer Ingelheim Pharmaceuticals — FDA Approval: 2015 Synjardy (empagliflozin and metformin hydrochloride) —… [read post]
11 Dec 2013, 1:39 pm
Or are they taking one for the team for Boehringer Ingelheim? [read post]
7 Jan 2021, 7:45 am
And Julie Steinberg of Bloomberg Law reports that “Boehringer Ingelheim Gets $1.25 Million Pradaxa Verdict Undone” (subscription required for full access). [read post]
16 Jan 2011, 11:45 pm
The Delhi Patent Office lately refused the Application Number 924/DELNP/2006 filed by Boehringer Ingelheim claiming polymorphic form II of anticoagulant drug dabigatran etexilate mesylate, marketed under the brand name Pradaxa. [read post]
31 Mar 2014, 7:58 am
Reuters reported than over 2,000 lawsuits in the US have been filed against German pharmaceutical firm Boehringer Ingelheim over its blockbuster blood thinning medicine Pradaxa (dabigatran etexilate). [read post]
16 Jan 2011, 11:45 pm
The Delhi Patent Office lately refused the Application Number 924/DELNP/2006 filed by Boehringer Ingelheim claiming polymorphic form II of anticoagulant drug dabigatran etexilate mesylate, marketed under the brand name Pradaxa. [read post]
2 May 2013, 10:30 am
On March 26, 2013, Plaintiff Lisa Mulhall filed a claim in the Illinois Southern District Court against the manufacturers of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for causing her mother’s death. [read post]
25 Jul 2012, 4:03 pm
Melvin Giles, Jr. sued Boehringer Ingelheim in the U.S. [read post]
25 Jul 2012, 4:03 pm
Melvin Giles, Jr. sued Boehringer Ingelheim in the U.S. [read post]
